hyaluronoglucosaminidase has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatham, JC; Davey, JR; Davidoff, AJ; De Blasio, MJ; Deo, M; Donner, DG; Erickson, JR; Gregorevic, P; Henstridge, DC; Kiriazis, H; Lees, JG; Lim, SY; Parry, LJ; Prakoso, D; Qian, H; Ritchie, RH; Tate, M; Wallace, RS | 1 |
1 other study(ies) available for hyaluronoglucosaminidase and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Topics: Aged; Animals; Antigens, Neoplasm; Cell Line; Class I Phosphatidylinositol 3-Kinases; Diabetic Cardiomyopathies; Disease Models, Animal; Female; Fibrosis; Gene Expression Regulation; Glycosylation; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Mice; Middle Aged; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Phenotype; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2022 |